| Jessica Nadine Larue, LMFTA | |
|
215 3rd Ave, Albemarle, NC 28001-4409 | |
| (980) 581-4305 | |
| Not Available |
| Full Name | Jessica Nadine Larue |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 215 3rd Ave, Albemarle, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336677095 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 12021A (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Nadine Larue, LMFTA 215 3rd Ave, Albemarle, NC 28001-4409 Ph: (704) 640-3487 | Jessica Nadine Larue, LMFTA 215 3rd Ave, Albemarle, NC 28001-4409 Ph: (980) 581-4305 |
News Archive
According to the editor of the scientific journal Nature, Dr Philip Campbell current procedures to assess and censor medical research potentially of use to terrorists need to be improved. He was speaking about the recent controversy regarding the bird flu virus H5N1 study. The study was initially stopped from publication fearing risk of bioterrorism. He was speaking to BBC News.
A new national survey on public attitudes toward medical applications and physical enhancements that rely on nanotechnology shows that support for the technology increases when the public is informed of the technology's risks as well as its benefits - at least among those people who have heard of nanotechnology.
A study by researchers at Royal Holloway, University of London, University College London and Oxford University, has found that a genetic variant which reduces the chance of contracting diseases such as tuberculosis and leprosy is more prevalent in populations with long histories of urban living.
Amgen today announced that results from the PRIME '203' and '181' pivotal Phase 3 trials evaluating Vectibix (panitumumab) in combination with chemotherapy (FOLFOX or FOLFIRI) as a first and second-line treatment for metastatic colorectal cancer (mCRC), respectively, were published online in the Journal of Clinical Oncology.
› Verified 8 days ago
Mrs. Shannon Marie Lomax, LMFTA Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 350 Pee Dee Ave, Albemarle, NC 28001 Phone: 704-986-1500 Fax: 800-227-8961 | |
Wendy A Caudle, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 124 E North St, Albemarle, NC 28001 Phone: 704-985-1088 Fax: 704-985-1341 | |
Mr. Vincent Paul Hughes, M.A. LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 350 Pee Dee Ave, Albemarle, NC 28001 Phone: 704-986-1500 Fax: 186-640-4562 |